{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:03:56Z","timestamp":1790773436457,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Norwegian PSC Research Center"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.bpg.2013.06.013","type":"journal-article","created":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T06:10:53Z","timestamp":1380607853000},"page":"531-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Liver abnormalities in bowel diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Martin","family":"Kummen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Schrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Muri","family":"Boberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2013.06.013_bib1","first-page":"206","article-title":"Versehluss der Gallenwege durch Verdiekang der Wandungen","volume":"39","author":"Hoffman","year":"1867","journal-title":"Arch Pathol Anat Physiol Klin Med"},{"key":"10.1016\/j.bpg.2013.06.013_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.013_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","article-title":"Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study","volume":"10","author":"Ricart","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib6","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.21949","article-title":"The liver in celiac disease","volume":"46","author":"Rubio-Tapia","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.013_bib7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1053\/gast.2002.32416","article-title":"Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure","volume":"122","author":"Kaukinen","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.013_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3748\/wjg.14.331","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease","volume":"14","author":"Saich","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib9","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.013_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365528209181041","article-title":"Sclerosing cholangitis in ulcerative colitis. A follow-up study","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/00365529709025107","article-title":"Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease","volume":"32","author":"Rasmussen","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","article-title":"Update on primary sclerosing cholangitis","volume":"42","author":"Karlsen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/CEG.S7556","article-title":"Hepatic manifestations of celiac disease","volume":"3","author":"Freeman","year":"2010","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cgh.2006.09.034","article-title":"Celiac disease and risk of liver disease: a general population-based study","volume":"5","author":"Ludvigsson","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2036.2005.02328.x","article-title":"Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association","volume":"21","author":"Lawson","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2013.06.013_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/MIB.0b013e3182802893","article-title":"Inflammatory bowel disease in primary sclerosing cholangitis: a robust yet changing relationship","volume":"19","author":"Sinakos","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1478-3231.2011.02607.x","article-title":"Evolving concepts in primary sclerosing cholangitis","volume":"32","author":"Krones","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2013.06.013_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2010.07.005","article-title":"Primary sclerosing cholangitis","volume":"24","author":"Karlsen","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2013.03.015","article-title":"Update on primary sclerosing cholangitis","volume":"59","author":"Karlsen","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib21","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the\u00a0recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.bpg.2013.06.013_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1478-3231.1999.tb00084.x","article-title":"Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease","volume":"19","author":"Hillan","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.bpg.2013.06.013_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.013_bib25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib26","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/hep.24307","article-title":"Three ulcerative colitis susceptibility loci\u00a0are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9","volume":"53","author":"Janse","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.013_bib27","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpg.2013.06.013_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.clinre.2012.02.003","article-title":"Genetics in primary sclerosing cholangitis","volume":"36","author":"N\u00e6ss","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib29","doi-asserted-by":"crossref","first-page":"19030","DOI":"10.1073\/pnas.1106408108","article-title":"Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype","volume":"108","author":"Rausch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2013.06.013_bib30","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis \u2013 Aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weism\u00fcller","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2013.06.013_bib32","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.013_bib35","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"J\u00f8rgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib37","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.013_bib38","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/ajg.2011.156","article-title":"High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"106","author":"Eaton","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib39","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/MIB.0b013e318286fa61","article-title":"Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Singh","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2013.06.013_bib42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.bpg.2013.06.013_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-102-5-581","article-title":"Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?","volume":"102","author":"Wee","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2013.06.013_bib45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bj\u00f6rnsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2013.06.013_bib46","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2013.06.013_bib48","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1586\/egh.13.5","article-title":"Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis","volume":"7","author":"Volta","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nri3407","article-title":"Triggers and drivers of autoimmunity: lessons from coeliac disease","volume":"13","author":"Sollid","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bpg.2013.06.013_bib53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.bpg.2013.06.013_bib54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/MIB.0b013e31828029a9","article-title":"The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease","volume":"19","author":"Wacklin","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib55","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/liv.12178","article-title":"Prevalence and causes of abnormal liver function in patients with coeliac disease","volume":"33","author":"Casella","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.bpg.2013.06.013_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ibd.21669","article-title":"Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-A case series and review of the literature","volume":"18","author":"McGowan","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib58","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ibd.20160","article-title":"Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients","volume":"13","author":"Gisbert","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib59","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.crohns.2012.10.015","article-title":"Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"7","author":"Sourianarayanane","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2013.06.013_bib60","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1572-0241.1999.01076.x","article-title":"The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease","volume":"94","author":"Lapidus","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21537","article-title":"Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study","volume":"45","author":"Parente","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl. 3","key":"10.1016\/j.bpg.2013.06.013_bib62","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1590-8658(03)00092-6","article-title":"Gallbladder motility in inflammatory bowel diseases","volume":"35","author":"Masclee","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3748\/wjg.v12.i1.70","article-title":"Gallbladder bile composition in patients with Crohn's disease","volume":"12","author":"Lapidus","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib64","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.13.6.415","article-title":"Lithogenic bile in patients with ileal dysfunction","volume":"13","author":"Dowling","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib65","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000201483","article-title":"Gallbladder hypokinesia in Crohn's disease","volume":"58","author":"Dami\u00e3o","year":"1997","journal-title":"Digestion"},{"key":"10.1016\/j.bpg.2013.06.013_bib66","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/003655200750056628","article-title":"Gallbladder motility in Crohn disease: influence of disease localization and bowel resection","volume":"35","author":"Vu","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib67","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1572-0241.1999.01221.x","article-title":"Gallbladder emptying and somatostatin and cholecystokinin plasma levels in celiac disease","volume":"94","author":"Fraquelli","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib68","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1440-1746.2004.03368.x","article-title":"Liver abscess in inflammatory bowel disease: report of two cases and review of the literature","volume":"19","author":"Margalit","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib69","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.crohns.2011.02.012","article-title":"Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: first case report","volume":"5","author":"Albuquerque","year":"2011","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2013.06.013_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/md.0b013e18064f9f3","article-title":"Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature","volume":"86","author":"Andr\u00e9","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bpg.2013.06.013_bib71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/DCR.0b013e318199db60","article-title":"Multiple aseptic liver abscesses as the initial manifestation of Crohn's disease: report of a case","volume":"52","author":"Zakout","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpg.2013.06.013_bib72","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(03)12830-9","article-title":"Amoebiasis","volume":"361","author":"Stanley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2013.06.013_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/003655401750064112","article-title":"Liver abscess caused by Clostridium difficile","volume":"33","author":"Sakurai","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib74","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2169\/internalmedicine.51.7908","article-title":"Successful treatment of a patient with sepsis and liver abscess caused by Edwardsiella tarda","volume":"51","author":"Ohara","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.bpg.2013.06.013_bib75","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2013.06.013_bib76","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib77","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/qjmed\/90.3.183","article-title":"Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden","volume":"90","author":"Jackson","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.bpg.2013.06.013_bib78","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11605-010-1336-2","article-title":"Mesenteric vascular thromboembolism in inflammatory bowel disease: a single center experience","volume":"15","author":"Jackson","year":"2011","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.bpg.2013.06.013_bib79","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.crohns.2011.10.003","article-title":"Portal vein thrombosis in inflammatory bowel diseases: a single-center case series","volume":"6","author":"Maconi","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bpg.2013.06.013_bib80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4254\/wjh.v3.i6.164","article-title":"Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy","volume":"3","author":"Dacha","year":"2011","journal-title":"World J Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib81","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1111\/j.1572-0241.2005.42029.x","article-title":"Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia","volume":"100","author":"Spina","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/MIB.0b013e31827eea5f","article-title":"Portomesenteric vein thrombosis in patients with inflammatory bowel disease","volume":"19","author":"Landman","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00054725-200111000-00003","article-title":"Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998","volume":"7","author":"Wester","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib84","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s10620-012-2549-x","article-title":"Inflammatory bowel disease and systemic AA amyloidosis","volume":"58","author":"Sattianayagam","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2013.06.013_bib85","first-page":"385","article-title":"Infliximab in the treatment of amyloidosis secondary to Crohn's disease","volume":"32","author":"Cabezuelo","year":"2012","journal-title":"Nefrologia"},{"key":"10.1016\/j.bpg.2013.06.013_bib86","doi-asserted-by":"crossref","first-page":"E74","DOI":"10.1097\/MIB.0b013e3182802bc9","article-title":"Systemic secondary amyloidosis in a 70-year-old patient with Crohn's disease: treatment with oral budesonide","volume":"19","author":"Wang","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jfma.2011.11.023","article-title":"Granulomatous liver diseases: a review","volume":"111","author":"Coash","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.bpg.2013.06.013_bib88","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ibd.21221","article-title":"Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts","volume":"16","author":"Jharap","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib89","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3748\/wjg.v19.i7.1040","article-title":"Use of thiopurines in inflammatory bowel disease","volume":"19","author":"Frei","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib90","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib91","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jcph.2","article-title":"Recent advances using immunomodulators for inflammatory bowel disease","volume":"53","author":"Nielsen","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bpg.2013.06.013_bib92","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3748\/wjg.v19.i11.1699","article-title":"Thiopurines in inflammatory bowel disease revisited","volume":"19","author":"B\u00e4r","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bpg.2013.06.013_bib93","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000320410","article-title":"Hepatotoxicity of agents used in the management of inflammatory bowel disease","volume":"28","author":"Khokhar","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib94","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib95","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cgh.2010.09.016","article-title":"A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease","volume":"9","author":"Kotlyar","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2013.06.013_bib96","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2474-9-48","article-title":"Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: a case series from a local surveillance of serious adverse events","volume":"9","author":"Jobanputra","year":"2008","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bpg.2013.06.013_bib97","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/gut.52.10.1530","article-title":"Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the committee on safety of medicines","volume":"52","author":"Logan","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2013.06.013_bib98","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ibd.21336","article-title":"Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-\u03b1) use for inflammatory bowel disease","volume":"17","author":"Coffin","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2013.06.013_bib99","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1542\/peds.2007-2248","article-title":"Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease","volume":"121","author":"Gura","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bpg.2013.06.013_bib100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0032-1329903","article-title":"Prevention and treatment of intestinal failure-associated liver disease in children","volume":"32","author":"Raphael","year":"2012","journal-title":"Semin Liver Dis"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691813001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:33:58Z","timestamp":1716024838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691813001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1521691813001261"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.013","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver abnormalities in bowel diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2013.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}